Delivery Order SPE2DB20D2104-SPE2DB25FMTPN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,044.86 and is classified as a non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Brilinta 60 mg tablets in quantities of 60 units, with a contract ceiling value of $1,387.10. This competitively awarded, firm fixed-price delivery order is set to be completed by September 15, 2025, and represents fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,533.10 to AmerisourceBergen Drug Corp for Brilinta 90 mg tablets (60-count units) on May 30, 2025, with completion scheduled for June 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. Brilinta is an antiplatelet medication commonly used in military and veteran healthcare systems for cardiovascular...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $1,514.37. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $4,769.52. This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside contract utilizing AmerisourceBergen's existing pharmaceutical supply agreement. The order will be fulfilled from the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Brilinta 60 mg tablets (60 count) valued at $1,109.68. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is due for completion by August 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Brilinta is an antiplatelet medication...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of BRILINTA 60 mg tablets. The firm-fixed-price contract, valued at $13,837.86, has an ultimate completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a wide range of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of BRILINTA 60 mg tablets (60-count packages) with a ceiling value of $1,709.58. This non-competitive, competitively awarded delivery order carries a firm fixed price structure and was completed on August 20, 2025, one day after the award date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract value of $1,780.51. This competitively awarded, firm fixed price delivery order is set to be completed by July 28, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and is issued as a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Brilinta 90 mg tablets in a 60-count configuration. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,236.96 and an ultimate completion date of September 22, 2025. The award was issued on September 19, 2025, with no set-aside designation applied. As a child contract...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMTPNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets in a quantity of 60-count units. This contract was competitively awarded without a set-aside designation and carries a ceiling value of $1,708.26 under firm fixed-price terms. The delivery order was awarded on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Brilinta is an antiplatelet medication commonly used in military and veteran healthcare systems for cardiovascular disease management. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of medical product deliveries with DLA across multiple therapeutic domains, supporting Defense Health Agency customers, the U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/18/25 |